Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Therapy
1.2.3 Adding An Anti-Androgen
1.2.4 Stopping An Anti-Androgen
1.2.5 Estrogens
1.2.6 Chemotherapy
1.2.7 Radiation Therapy
1.2.8 Others
1.3 Market by Application
1.3.1 Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Castration Resistant Prostate Cancer Treatment Market Perspective (2016-2027)
2.2 Castration Resistant Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Castration Resistant Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Castration Resistant Prostate Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Castration Resistant Prostate Cancer Treatment Industry Dynamic
2.3.1 Castration Resistant Prostate Cancer Treatment Market Trends
2.3.2 Castration Resistant Prostate Cancer Treatment Market Drivers
2.3.3 Castration Resistant Prostate Cancer Treatment Market Challenges
2.3.4 Castration Resistant Prostate Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue
3.1.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Castration Resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Castration Resistant Prostate Cancer Treatment Revenue
3.4 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Castration Resistant Prostate Cancer Treatment Revenue in 2020
3.5 Castration Resistant Prostate Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service
3.7 Date of Enter into Castration Resistant Prostate Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Castration Resistant Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Castration Resistant Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
6.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type
6.2.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Application
6.3.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Castration Resistant Prostate Cancer Treatment Market Size by Country
6.4.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
7.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type
7.2.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application
7.3.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country
7.4.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
9.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type
9.2.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application
9.3.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country
9.4.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Active Biotech
11.1.1 Active Biotech Company Details
11.1.2 Active Biotech Business Overview
11.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Introduction
11.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.1.5 Active Biotech Recent Development
11.2 Diagnocure
11.2.1 Diagnocure Company Details
11.2.2 Diagnocure Business Overview
11.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Introduction
11.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.2.5 Diagnocure Recent Development
11.3 Glaxosmithkline
11.3.1 Glaxosmithkline Company Details
11.3.2 Glaxosmithkline Business Overview
11.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Introduction
11.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.3.5 Glaxosmithkline Recent Development
11.4 Northwest Biotherapeutics
11.4.1 Northwest Biotherapeutics Company Details
11.4.2 Northwest Biotherapeutics Business Overview
11.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Introduction
11.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.4.5 Northwest Biotherapeutics Recent Development
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Details
11.5.2 Millennium Pharmaceuticals Business Overview
11.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.5.5 Millennium Pharmaceuticals Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Castration Resistant Prostate Cancer Treatment Introduction
11.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.6.5 Hologic Recent Development
11.7 Spectrum Pharmaceuticals
11.7.1 Spectrum Pharmaceuticals Company Details
11.7.2 Spectrum Pharmaceuticals Business Overview
11.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.7.5 Spectrum Pharmaceuticals Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Introduction
11.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Bayer Healthcare Pharmaceuticals
11.9.1 Bayer Healthcare Pharmaceuticals Company Details
11.9.2 Bayer Healthcare Pharmaceuticals Business Overview
11.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.9.5 Bayer Healthcare Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Adding An Anti-Androgen
Table 4. Key Players of Stopping An Anti-Androgen
Table 5. Key Players of Estrogens
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. Key Players of Others
Table 9. Global Castration Resistant Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Castration Resistant Prostate Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Castration Resistant Prostate Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2016-2021)
Table 13. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2022-2027)
Table 15. Castration Resistant Prostate Cancer Treatment Market Trends
Table 16. Castration Resistant Prostate Cancer Treatment Market Drivers
Table 17. Castration Resistant Prostate Cancer Treatment Market Challenges
Table 18. Castration Resistant Prostate Cancer Treatment Market Restraints
Table 19. Global Castration Resistant Prostate Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Castration Resistant Prostate Cancer Treatment Market Share by Players (2016-2021)
Table 21. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2020)
Table 22. Ranking of Global Top Castration Resistant Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service
Table 26. Date of Enter into Castration Resistant Prostate Cancer Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Castration Resistant Prostate Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Active Biotech Company Details
Table 67. Active Biotech Business Overview
Table 68. Active Biotech Castration Resistant Prostate Cancer Treatment Product
Table 69. Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 70. Active Biotech Recent Development
Table 71. Diagnocure Company Details
Table 72. Diagnocure Business Overview
Table 73. Diagnocure Castration Resistant Prostate Cancer Treatment Product
Table 74. Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 75. Diagnocure Recent Development
Table 76. Glaxosmithkline Company Details
Table 77. Glaxosmithkline Business Overview
Table 78. Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product
Table 79. Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 80. Glaxosmithkline Recent Development
Table 81. Northwest Biotherapeutics Company Details
Table 82. Northwest Biotherapeutics Business Overview
Table 83. Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product
Table 84. Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 85. Northwest Biotherapeutics Recent Development
Table 86. Millennium Pharmaceuticals Company Details
Table 87. Millennium Pharmaceuticals Business Overview
Table 88. Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 89. Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 90. Millennium Pharmaceuticals Recent Development
Table 91. Hologic Company Details
Table 92. Hologic Business Overview
Table 93. Hologic Castration Resistant Prostate Cancer Treatment Product
Table 94. Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 95. Hologic Recent Development
Table 96. Spectrum Pharmaceuticals Company Details
Table 97. Spectrum Pharmaceuticals Business Overview
Table 98. Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 99. Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 100. Spectrum Pharmaceuticals Recent Development
Table 101. Abbott Laboratories Company Details
Table 102. Abbott Laboratories Business Overview
Table 103. Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 104. Abbott Laboratories Recent Development
Table 105. Bayer Healthcare Pharmaceuticals Company Details
Table 106. Bayer Healthcare Pharmaceuticals Business Overview
Table 107. Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 108. Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 109. Bayer Healthcare Pharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Castration Resistant Prostate Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Therapy Features
Figure 3. Adding An Anti-Androgen Features
Figure 4. Stopping An Anti-Androgen Features
Figure 5. Estrogens Features
Figure 6. Chemotherapy Features
Figure 7. Radiation Therapy Features
Figure 8. Others Features
Figure 9. Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Castration Resistant Prostate Cancer Treatment Report Years Considered
Figure 13. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2022-2027)
Figure 17. Global Castration Resistant Prostate Cancer Treatment Market Share by Players in 2020
Figure 18. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue in 2020
Figure 20. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 24. North America Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 25. North America Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 26. United States Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 30. Europe Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 31. Europe Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 32. Germany Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Region (2016-2027)
Figure 42. China Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 62. Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 63. Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 64. Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 65. Millennium Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 66. Hologic Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 67. Spectrum Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 68. Abbott Laboratories Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 69. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs